Search

Your search keyword '"Franke, A. (Andre)"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Franke, A. (Andre)" Remove constraint Author: "Franke, A. (Andre)"
38 results on '"Franke, A. (Andre)"'

Search Results

1. Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial.

3. Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline

4. The power of genetic diversity in genome-wide association studies of lipids

5. Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4

6. Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4

7. Health-related quality-of-life (HRQoL) analysis from a randomized phase II trial of androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415.

8. Abstract PS13-25: Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study

9. Translation of mouse model to human gives insights into periodontitis etiology

10. Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) versus AAP+APA in patients with advanced prostate cancer with noncastrate testosterone levels: (LACOG 0415).

11. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

12. Associations of autozygosity with a broad range of human phenotypes

13. Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria

14. Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: Patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial

15. Associations of autozygosity with a broad range of human phenotypes

16. Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial

17. Phase III MONALEESA-7 trial of premenopausal patients with HR+/HER2− advanced breast cancer (ABC) treated with endocrine therapy ± ribociclib: Overall survival (OS) results.

18. In-depth gene expression analysis of premenopausal patients with HR+/HER2− advanced breast cancer (ABC) treated with ribociclib-containing therapy in the Phase III MONALEESA-7 trial.

19. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

20. Genome-wide association meta-analysis of coronary artery disease and periodontitis reveals a novel shared risk locus

21. Meta-analysis of human genome-microbiome association studies: The MiBioGen consortium initiative

22. Corrigendum: A genome-wide association study identifies nucleotide variants at SIGLEC5 and DEFA1A3 as risk loci for periodontitis [Human Molecular Genetics., 26, 13, (2017) (2577-2588)]

23. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

24. Association between telomere length and risk of cancer and non-neoplastic diseases a mendelian randomization study

25. Checkmate 649: A randomized, multicenter, open-label, phase 3 study of nivolumab (Nivo) plus ipilimumab (Ipi) versus oxaliplatin plus fluoropyrimidine in patients (Pts) with previously untreated advanced or metastatic gastric (G) or gastroesophageal junction (GEJ) cancer.

26. CheckMate 577: A randomized, double-blind, phase 3 study of nivolumab (Nivo) or placebo in patients (Pts) with resected lower esophageal (E) or gastroesophageal junction (GEJ) cancer.

27. Pooled resequencing of 122 ulcerative colitis genes in a large Dutch cohort suggests population-Specific associations of rare variants in MUC2

28. Meta-analysis identifies seven susceptibility loci involved in the atopic March

29. Recurrent Coding Sequence Variation Explains only A Small Fraction of the Genetic Architecture of Colorectal Cancer

30. Genome-wide association study of kidney function decline in individuals of European descent

31. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation

32. Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization

33. A common biological basis of obesity and nicotine addiction

34. Common variants in mendelian kidney disease genes and their association with renal function

35. Genome-wide association and functional follow-up reveals new loci for kidney function

36. A discrete event modelling framework for simulation of long-term outcomes of sequential treatment strategies for ankylosing spondylitis

37. A meta-analysis of genome-wide data from five European isolates reveals an association of COL22A1, SYT1, and GABRR2 with serum creatinine level

38. Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: Patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial

Catalog

Books, media, physical & digital resources